glp-1 obesity drugs updates today What is the pipeline for future medications for obesity? Use of diabetes and anti-obesity
Description
45,160 In summary, most of the studied drugs did not show clinically significant DDIs related to delayed gastric emptying caused by GLP-1 RAs or a dual GLP-1/GIP RA administration
A structured diet plan can help maintain progress during this gap
May 30, 2025
Vitamin D supplementation and muscle strength in pre-sarcopenic elderly Lebanese people: a randomized controlled trial
